Please login to the form below

Not currently logged in
Email:
Password:

Ruvise

This page shows the latest Ruvise news and features for those working in and with pharma, biotech and healthcare.

Novartis withdraws application for Ruvise approval in EU

Novartis withdraws application for Ruvise approval in EU

Novartis withdraws application for Ruvise approval in EU. Had submitted imatinib mesylate for use in hypertension. ... The European Medicines Agency (EMA) has said that Novartis has withdrawn its marketing application for Ruvise in the treatment of high

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics